Utilizing primary data amassed from in-depth interviews with primary care physicians and cancer specialists across the seven major markets of the US, Japan, France, Germany, Italy, Spain and the UK, this report provides a detailed analysis of the diagnosis and treatment of lung cancer. A comparison is presented of current medical practice in lung cancer treatment, alongside key global conclusions and input from opinion leading lung cancer specialists.
